The odds of a prescription for systemic estrogens, combined estrogens and progestogens for hormonal contraceptives, progestogens only, and GnRH agonists were not significantly different based on the presence of co-occurring depression and/or anxiety. This evidence concerns the gene GNRH1 and depressive disorder.